XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Deficit - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 03, 2022
Apr. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Apr. 22, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Expected dividend yield     0.00% 0.00% 0.00% 0.00%    
Weighted average grant date fair value per share of option grants     $ 9.36   $ 7.31      
Stock options granted           0 0  
Stock options exercised         0 0    
Total unrecognized stock-based compensation cost     $ 8,500   $ 8,500      
Total unrecognized stock-based compensation cost expected to be recognized over remaining weighted-average period         3 years 7 months 28 days      
Net proceeds from initial public offering         $ 230,006      
Increase in number of authorized shares of common stock     500,000,000   500,000,000   50,000,000 50,000,000
Increase in number of authorized shares of preferred stock     50,000,000   50,000,000   0  
Number of shares initially available for issuance under awards granted     4,791,550   4,791,550      
Initial Public Offering                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Sale of common stock 13,529,750              
Public offering price per share $ 17.00              
Net proceeds from initial public offering $ 209,500              
Underwriting discounts, commissions and offering costs $ 20,500              
Increase in number of authorized shares of common stock 500,000,000              
Increase in number of authorized shares of preferred stock 50,000,000              
Common Stock                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Sale of common stock           1,606,815    
Common Stock | Initial Public Offering                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Sale of common stock     13,529,750   13,529,750      
2021 Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Plan term         ten years      
Vesting period         4 years      
Stock options granted         804,384      
Number of shares initially available for issuance under awards granted   216,849            
Share based compensation arrangement by share-based payment award, terms of award         ten years      
2022 Incentive Award Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Plan term   The 2022 Plan became effective in connection with the Company’s IPO and will remain in effect until the tenth anniversary of its effective date, which will be April 28, 2032, unless earlier terminated by the Company’s board of directors. The number of shares of the Company's common stock initially available for issuance under awards granted pursuant to the 2022 Plan was the sum of (1) 4,900,000 shares of the Company’s common stock, plus (2) 216,849 shares remaining available for issuance under the 2021 Plan as of the effective date of the 2022 Plan, plus (3) any shares subject to outstanding awards under the 2021 Plan as of the effective date of the 2022 Plan that become available for issuance under the 2022 Plan thereafter in accordance with its terms.            
Number of shares initially available for issuance under awards granted   4,900,000 5,116,849   5,116,849      
Share based compensation arrangement by share-based payment award, terms of award   The 2022 Plan became effective in connection with the Company’s IPO and will remain in effect until the tenth anniversary of its effective date, which will be April 28, 2032, unless earlier terminated by the Company’s board of directors. The number of shares of the Company's common stock initially available for issuance under awards granted pursuant to the 2022 Plan was the sum of (1) 4,900,000 shares of the Company’s common stock, plus (2) 216,849 shares remaining available for issuance under the 2021 Plan as of the effective date of the 2022 Plan, plus (3) any shares subject to outstanding awards under the 2021 Plan as of the effective date of the 2022 Plan that become available for issuance under the 2022 Plan thereafter in accordance with its terms.            
Shares issuance, ending year   2032            
Percentage of shares issued from outstanding number of shares   5.00%            
Shares issuance, beginning year   2023            
2022 Employee Stock Purchase Plan                
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                
Shares reserved for issuance   410,000            
Maximum number of shares that may be authorized in accordance with plan   10,000,000            
Shares issuance, ending year   2032            
Percentage of shares issued from outstanding number of shares   1.00%            
Purchase price of common stock, percent   85.00%            
Shares issuance, beginning year   2023